Organon & Co.

NYSE:OGN

14.96 (USD) • At close March 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20242023202220212020201920182017
Operating Activities:
Net Income 8641,0239171,3512,1603,3062,1531,801
Depreciation & Amortization 1322362121951573331,6731,973
Deferred Income Tax -160-485-18-28861237-1,045
Stock Based Compensation 105101755940415656
Change In Working Capital 0-155-452702-197-672-174-1,435
Accounts Receivables 383-212-123-277159200250533
Inventory -131-230-220-138-29-914472
Accounts Payables -157163-23766327-3520-14
Other Working Capital 0124128454-354-746-488-2,026
Other Non Cash Items -2791244397-253-585,480
Operating Cash Flow 9397998582,4582,1872,7673,6873,419
Investing Activities:
Investments In Property Plant And Equipment -175-259-427-488-278-92-101-86
Acquisitions Net -166-2-124-185573230
Purchases Of Investments 00000000
Sales Maturities Of Investments 00000000
Other Investing Activites -172113119215-173230
Investing Cash Flow -513-260-420-481-258-102-69-56
Financing Activities:
Debt Repayment -11-258-1087,8461,512059-4
Common Stock Issued 001100000
Common Stock Repurchased 0-17-1100000
Dividends Paid -297-294-290-1450000
Other Financing Activities -60-17-35-9,034-3,687-2,621-4,223-3,368
Financing Cash Flow -368-569-433-1,333-2,175-2,621-4,164-3,372
Other Information:
Effect Of Forex Changes On Cash -7617-3623-33119-36
Net Change In Cash -18-13-31667-24975-527-45
Cash At End Of Period 67569370673770319244771